myeloproliferative

Clinical Analysis of 126 Cases of Myeloproliferative Disease

骨髓增殖性疾病126例临床病例分析

Auxiliary Treatment of Myeloproliferative Syndrome by Umbilical Blood and Nursing Care

脐血辅助治疗骨髓增生异常综合征疗效观察及护理

Clinical Study of Myeloproliferative Disease with Stroke

骨髓增殖性疾病伴脑卒中的临床研究

Analysis of clinical and biological characteristics of myeloplastic and myeloproliferative disorders in children

儿童骨髓增生异常/骨髓增殖性疾病临床及生物学特征分析

Objective To investigate the law of evolvement and transformation of myeloproliferative disorders syndrome ( MDS ) .

目的探索小儿骨髓增生异常综合征（MDS）演变和转化规律。

Clinical study of homoharringtonine and low-dose cytarabine in myeloproliferative diseases

高三尖杉酯碱联合小剂量阿糖胞苷治疗骨髓增殖性疾病疗效观察

Chinese medicine treatment the myeloproliferative neoplasms can be achieved to improve symptoms , long-term control of the disease and low side effects .

中药治疗骨髓增殖性肿瘤能够达到改善症状，长期控制病情，副作用小的效果。

Thrombelastograph examination in patients with chronic myeloproliferative disease

慢性骨髓增殖性疾病患者TEG检测的变化

A Clinical Study on the Treatment of Myeloproliferative Syndrome by Strengthening Qi , Nourishing Yin and Activating the Blood

益气养阴活血治疗骨髓增生异常综合征临床研究

Clinical observation of hemapheresis and chemotherapy for myeloproliferative diseases

血细胞单采去除术联合化疗治疗骨髓增殖性疾病临床疗效观察

Conditions included myelodysplastic syndrome , myeloproliferative disorders , acute myeloid leukemia , and bronchial carcinoma .

疾病可引发脊髓发育不良、脊髓增殖失调，急性髓性白血病和支气管瘤。

Timonacic in therapy of 8 patients of myeloproliferative disorders

噻唑烷酸治疗8例骨髓增生病

Features of the related myeloproliferative disorder included isolated erythrocytosis , distinctive bone marrow morphology , and reduced serum erythropoietin levels .

相关骨髓增生碍的主要特征为：独立的红细胞增多，特征性的骨髓心态学以及血清中促红细胞生成素的减少。

Conclusions Myeloid sarcoma may precede , develop in a background of myeloproliferative disorder or even after remission of the disease .

结论髓系肉瘤可孤立出现或发生于各种骨髓增生性疾病的病程中或经治疗缓解后。

Objective To explore the relationship between myeloproliferative disorders ( MPD ) and calcitonin ( CT ) gene hypermethylation .

目的探讨骨髓增生性疾病（MPD）与降钙素（CT）基因高度甲基化的关系。

In BCR-ABL fusion gene negative myeloproliferative diseases , the discovery of JAK2V617F point mutation is an important landmark .

在BCR-ABL阴性的骨髓增殖性疾病的发病机制中，JAK2V617F点突变的发现是一个重大的突破。

This paper presents the results of the treatment of 50 cases of myeloproliferative syndrome by strengthening qi , nourishing yin and activating the blood .

骨髓增生异常综合征（HDS）是一种恶性血液病，目前尚缺乏有效的治疗手段。本文采用益气养阴活血法治疗MDS50例，对症治疗MDS10例为对照组。

Hematostatic Function in Myeloproliferative Diseases

骨髓增生性疾病止血功能的研究

Methords Hemapheresis was done once or twice weekly , followed by hydroxyurea chemotherapy in 38 patients with of myeloproliferative diseases .

方法38例骨髓增殖性疾病进行血细胞单采去除术每周1~2次，同时给予羟基脲化疗。

Chronic myelogenous leukemia ( CML ) is a clonal myeloproliferative disorder due to an acquired abnormality in a pluripotential hematopoietic stem cell .

慢性粒细胞白血病（ChronicMyelogenousLeukemia，CML，简称慢粒）是一种起源于多能干细胞异常克隆的恶性增殖性疾病。

There is high frequency of JAK2 V617F mutation in myeloproliferative disorders and it could be used as the diagnostic marker for myeloproliferative disorders .

JAK2基因V617F突变在骨髓增殖性疾病中有较高的检出率，可作为骨髓增殖性疾病特异性诊断指标。

It has been reported in association with acute myeloid leukemia , myeloproliferative disorders , and myelodysplasia in blast transformation , as well as in patients with no known hematological disorders .

它曾被报告与淋巴母细胞转变相关的急性骨髓性白血病、骨髓增生性疾病、脊髓发育不全症等等，甚至于那些不具已知的血液学异常相关的病人们身上。

Hematological abnormalities may be attributable to the direct and indirect effects of HIV infection , to opportunistic infections , and to the toxicity of therapeutic agents . HIV infection can induce myelodysplastic syndromes ( MDS ), myeloproliferative disorders ( MPD ) and T cell lymphomas .

血液系统异常归因于HIV感染、机会感染和治疗药物的直接和间接作用，可与MDS、骨髓增生性疾患（MPD）和T细胞淋巴瘤相混淆。